Industry Strength Score
11/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
GLUCOTRACK INC (GCTK) Stock Price & Overview
NASDAQ:GCTK • US45824Q8042
Current stock price
0.8 USD
-0.05 (-6.31%)
At close:
0.76 USD
-0.04 (-5%)
After Hours:
The current stock price of GCTK is 0.8 USD. Today GCTK is down by -6.31%. In the past month the price decreased by -6.98%. In the past year, price decreased by -92.1%.
GCTK Key Statistics
52-Week Range0.619 - 15.9
Current GCTK stock price positioned within its 52-week range.
1-Month Range0.63 - 1.28
Current GCTK stock price positioned within its 1-month range.
- Market Cap
- 1.552M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- N/A
- Dividend Yield
- N/A
GCTK Stock Performance
Today
-6.31%
1 Week
+9.10%
1 Month
-6.98%
3 Months
-58.12%
Longer-term
6 Months -87.64%
1 Year -92.10%
2 Years -99.97%
3 Years -99.97%
5 Years N/A
10 Years N/A
GCTK Stock Chart
GCTK Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to GCTK. When comparing the yearly performance of all stocks, GCTK is a bad performer in the overall market: 98.55% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
GCTK Earnings
Next Earnings DateN/A
Last Earnings DateN/A
PeriodQ4 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
GCTK Forecast & Estimates
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
GCTK Financial Highlights
Income Statements
Revenue(TTM)N/A
Net Income(TTM)N/A
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A
GCTK Ownership
Ownership
Inst Owners9.52%
Shares1.94M
Float1.89M
Ins Owners0.65%
Short Float %35.48%
Short Ratio0.46
GCTK Industry Overview
GCTK operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 127 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
60/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
22%
Outperformed 22% of sub-industries
3 Month Rank
14%
Outperformed 14% of sub-industries
6 Month Rank
11%
Outperformed 11% of sub-industries
Industry Fundamentals & Breadth
- Members
- 127
- New Highs
- 2.4%
- New Lows
- 14.2%
- Average ROE
- 17.2%
- Average Profit Margin
- 20.3%
- Average Operating Margin
- 22.5%
- Average P/E
- 28.1
- Average Fwd P/E
- 27.3
- Average Debt/Equity
- 0.5
GCTK Latest News, Press Relases and Analysis
GCTK Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 39.25 | 162.529B | ||
| ABT | ABBOTT LABORATORIES | 14.24 | 157.763B | ||
| SYK | STRYKER CORP | 17.41 | 120.688B | ||
| BSX | BOSTON SCIENTIFIC CORP | 14.31 | 85.619B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.9 | 48.141B | ||
| IDXX | IDEXX LABORATORIES INC | 38.32 | 44.539B | ||
| BDX | BECTON DICKINSON AND CO | 10.94 | 42.438B | ||
| RMD | RESMED INC | 16.7 | 31.148B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 10.74 | 27.761B | ||
| DXCM | DEXCOM INC | 20.18 | 22.918B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 9.11 | 15.956B | ||
| PEN | PENUMBRA INC | 63.83 | 12.837B | ||
| GMED | GLOBUS MEDICAL INC - A | 20.03 | 12.197B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About GCTK
Company Profile
GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company is headquartered in Rutherford, New Jersey and currently employs 11 full-time employees. The company went IPO on 2013-04-09. The firm is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. The company has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The firm has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.
Company Info
IPO: 2013-04-09
GLUCOTRACK INC
301 Rt 17 North, Suite 800
Rutherford NEW JERSEY US
Employees: 11
Phone: 197286757878
GLUCOTRACK INC / GCTK FAQ
What does GLUCOTRACK INC do?
GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company is headquartered in Rutherford, New Jersey and currently employs 11 full-time employees. The company went IPO on 2013-04-09. The firm is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. The company has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The firm has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.
What is the current price of GCTK stock?
The current stock price of GCTK is 0.8 USD. The price decreased by -6.31% in the last trading session.
Does GLUCOTRACK INC pay dividends?
GCTK does not pay a dividend.
What is the ChartMill rating of GLUCOTRACK INC stock?
GCTK has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Can you provide the ownership details for GCTK stock?
You can find the ownership structure of GLUCOTRACK INC (GCTK) on the Ownership tab.